Fan Z et al., 2014-03-06: Nanoparticle study in which methylene blue bound to a nanoplatform killed LNCaP prostate cancer cells only when activated by 785 nm near-infrared light; without light there was no cytotoxicity.
No cytotoxicity was observed in the absence of NIR light. Targeted photodynamic and photothermal treatment using 785 nm NIR light indicates that the multimodal treatment enhances the possibility of destroying LNCaP prostate cancer cells in vitro dramatically.
Fan Z et al., 2014-03-06: Nanoparticle study in which methylene blue bound to a nanoplatform killed LNCaP prostate cancer cells only when activated by 785 nm near-infrared light; without light there was no cytotoxicity. C3 Fan 2014 (prostate). Study type: in vitro cell-line study (LNCaP) with a methylene blue-bound nanoparticle. Country: USA (Jackson State University and University of Mississippi Medical Center). Dose: not stated in the abstract text captured. Light: 785 nm NIR, photodynamic plus photothermal. Funder: US NIH (G12 RR013459, T34 GM007672) and a non-PHS federal award. Conflicts: none declared in the record. Comparator: cells without NIR light. Note the agent is a methylene blue NANOPARTICLE, not free methylene blue. Also filed as MTN-03 (claims C1, C3). Study type: lab.
